Taylor B. Guo

University of California, Los Angeles — United States

Immunology and Microbiology · Life Sciences

20h-index1.9kcitations53works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(8), T-cell and B-cell Immunology(7), Immunotherapy and Immune Responses(7), Monoclonal and Polyclonal Antibodies Research(7), Cancer, Hypoxia, and Metabolism(4)

Publications53 total

Open-Source Touchscreen-Equipped Operant Boxes: Custom-Built, Modular, and Affordable Systems for Modern Experimental Needs
2025Open Access
Open-Source Touchscreen-Equipped Operant Boxes: Custom-Built, Modular, and Affordable Systems for Modern Experimental Needs
2025Open Access
Synergistic Changes in Ascorbic Acid and Soluble Sugar Contents in Apricot Fruits and the Related Regulatory Mechanisms
Food Science & Nutrition·2025Open Access
Unusual Art Patterns in a Pigeon named Darwin Following Sudden Feather Loss: A Case Study of Stress-Induced Behavioral Change
2025Open Access
Power corrections in the determination of heavy meson light-cone distribution amplitudes: A renormalon-based estimation
Physical review. D/Physical review. D.·2025· 2 citedOpen Access
Abstract 1871: Discovery and characterization of NXV01c, an EGFR × cMET bispecific nanobody drug conjugate with potent anti-tumor activity
Cancer Research·2024· 2 cited
Abstract B144: Discovery and preclinical evaluation of novel oral WEE1 degraders
Molecular Cancer Therapeutics·2023
Abstract B131: NXC03, an AI-designed, affinity-attenuated IL-21 mutein with half-life extension enhances antitumor immunity
Molecular Cancer Therapeutics·2023
Discovery of BCL-XL Heterobifunctional Degrader with Potentially Improved Therapeutic Window and Minimal Platelet Toxicity for Hematological Malignancies
Blood·2023· 2 cited
1364 Discovery of NXA01, a novel CD24 antibody with tumor selectivity and potent anti-tumor activity
Regular and Young Investigator Award Abstracts·2023· 1 citedOpen Access
Abstract 5558: Discovery of a novel Claudin 6 X 4-1BB bispecific antibody with potent anti-tumor activity through conditional 4-1BB activation
Cancer Research·2022
Abstract 4228: Inhibition of B7-H3 by enoblituzumab elicits antitumor immune modulation in both innate and adaptive immunity
Cancer Research·2022
702 TJ-CD4B (ABL111), a Claudin18.2-targeted 4-1BB tumor engager induces potent tumor-dependent immune response without dose-limiting toxicity in preclinical studies
Regular and Young Investigator Award Abstracts·2021· 3 citedOpen Access
775b Olamkicept, an IL-6 Trans-Signaling Inhibitor, is Effective for Induction of Response and Remission in A Randomized, Placebo-Controlled Trial in Moderate to Severe Ulcerative Colitis
Gastroenterology·2021· 12 cited
Abstract 1871: A differentiated CD73 blocking antibody with a unique intra-dimer binding mechanism for cancer immunotherapy
Cancer Research·2021· 1 cited
Bispecific antibodies: the next generation of immuno-oncology drugs
Drug target review·2020
Abstract 5644: Claudin 18.2 X 4-1BB bispecific antibody induced potent tumor inhibition through tumor-specific 4-1BB activation
Cancer Research·2020· 2 cited
Abstract 5622: A novel immunocytokine fusion protein combining tumor-targeting anti-CD47 antibody with GM-CSF cytokine for enhanced antitumor efficacy
Cancer Research·2018· 2 cited
Retraction Note: Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease
Nature Medicine·2013Open Access
Novel complex crystal structure of prolyl hydroxylase domain-containing protein 2 (PHD2): 2,8-Diazaspiro[4.5]decan-1-ones as potent, orally bioavailable PHD2 inhibitors
Bioorganic & Medicinal Chemistry·2013· 17 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jingwu Z. Zhang(8), Hongtao Lu(8), Binyao Wang(7), Xuebin Liu(5), Bing Wan(5), Lei Fang(5), Ailian Liu(5), Feng Ren(5), Jia‐Ning Xiang(5), John D. Elliott(5), Xichen Lin(5), Laura V. Gatica(5), Víctor Nacher(5), Huahua Fan(5), Qin Shao(5), Jean‐Charles Fruchart(5), Mohamed Naceur Slimane(5), Hafid Mezdour(5), Mustapha Rouis(5), Fanny Zirulnik(5)